|
| Status |
Public on Apr 21, 2017 |
| Title |
post9 |
| Sample type |
SRA |
| |
|
| Source name |
AA patient_post-treatment
|
| Organism |
Homo sapiens |
| Characteristics |
subject status: patients with Alopecia Areata
time point: at 8 weeks of treatment with Tofacitinib Citrate 5 mg BID
tissue: scalp biopsy
|
| Extracted molecule |
total RNA |
| Extraction protocol |
poly-A pull-down
library preparation using Illumina TruSeq RNA prep kit
|
| |
|
| Library strategy |
RNA-Seq |
| Library source |
transcriptomic |
| Library selection |
cDNA |
| Instrument model |
Illumina HiSeq 2000 |
| |
|
| Data processing |
alignment was performed to mouse genome build NCBI/build37.2 using Tophat. Differential expression analysis for RNASeq was performed using DESeq.
Genome_build: NCBI/build37.2
Supplementary_files_format_and_content: RNASeq normalized counts, text file
|
| |
|
| Submission date |
Apr 26, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Anthony Oro |
| E-mail(s) |
oro@stanford.edu
|
| Organization name |
Stanford University
|
| Department |
Dermatology
|
| Lab |
Oro
|
| Street address |
269 Campus Drive, CCSR 2145c
|
| City |
Stanford |
| State/province |
CA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platform ID |
GPL11154 |
| Series (1) |
| GSE80688 |
Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate for Alopecia Areata and Variants |
|
| Relations |
| BioSample |
SAMN04903196 |
| SRA |
SRX1728030 |
